Inventor · disambiguated record
Johan Neyts
Also filed as: NEYTS JOHAN
34 granted patents·16 pending applications·129 citations·filing 2003–2024
96Inventor score
Top patents by PatentIndex Score
50 records- 0192US8658616B2Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virusMCGUIGAN CHRISTOPHER·Filed 2007·Granted Feb 25, 2014·55 cites·22 claims
- 0285US8329727B2Imidazo[4,5-c]pyridine compounds and methods of antiviral treatmentBONDY STEVEN S·Filed 2009·Granted Dec 11, 2012·9 cites·37 claims
- 0384US7648998B2Imidazo 4,5-c pyridine compounds and methods of antiviral treatmentLEUVEN K U RES & DEV·Filed 2004·Granted Jan 19, 2010·20 cites·33 claims
- 0483US8779141B2Viral inhibitorsNEYTS JOHAN·Filed 2009·Granted Jul 15, 2014·8 cites·1 claims
- 0581US10058516B2Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activityUNIV MARYLAND·Filed 2016·Granted Aug 28, 2018·2 cites·14 claims
- 0679US10226434B2Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activityUNIV MARYLAND·Filed 2018·Granted Mar 12, 2019·3 cites·12 claims
- 0777US8796273B2Compound for the treatment of enterovirusesNEYTS JOHAN·Filed 2011·Granted Aug 5, 2014·3 cites·7 claims
- 0876US9951058B2Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2017·Granted Apr 24, 2018·2 cites·14 claims
- 0976US2025099568A1Chimeric Flavivirus Lyssavirus VaccinesUNIV LEUVEN KATH·Filed 2024·Application pending·0 cites
- 1075US9890133B2Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseasesKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Feb 13, 2018·2 cites·18 claims
- 1174US10550123B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2012·Granted Feb 4, 2020·3 cites·17 claims
- 1273US9833423B21,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredientKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Dec 5, 2017·2 cites·18 claims
- 1373US7790730B2Imidazo[4,5-d]pyrimidines, their uses and methods of preparationGILEAD SCIENCES INC·Filed 2005·Granted Sep 7, 2010·2 cites·63 claims
- 1472US9790197B2Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2013·Granted Oct 17, 2017·2 cites·4 claims
- 1572US9464067B2Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseasesJUNG YOUNG SIK·Filed 2012·Granted Oct 11, 2016·3 cites·19 claims
- 1672US2025188066A1Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1770US2025090491A1Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1869US9346749B21,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredientJUNG YOUNG SIK·Filed 2012·Granted May 24, 2016·2 cites·20 claims
- 1968US12012411B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2021·Granted Jun 18, 2024·0 cites·18 claims
- 2068US8404707B2Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitorsNEYTS JOHAN·Filed 2007·Granted Mar 26, 2013·3 cites·5 claims
- 2168US7737162B2Viral inhibitorsGILEAD SCIENCES INC·Filed 2003·Granted Jun 15, 2010·4 cites·9 claims
- 2267US8741856B2Avermectins and milbemycins for the treatment, prevention or amelioration of flavivirus infectionsMILANI DE MAYO DE MARI MARIO·Filed 2010·Granted Jun 3, 2014·2 cites·7 claims
- 2365US12286423B2Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2021·Granted Apr 29, 2025·0 cites·4 claims
- 2465US12083092B2Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2021·Granted Sep 10, 2024·0 cites·31 claims
- 2565US12070494B2Chimeric flavivirus lyssavirus vaccinesUNIV LEUVEN KATH·Filed 2019·Granted Aug 27, 2024·0 cites·23 claims
- 2664US2023406889A1Live-attenuated flaviviruses with heterologous antigensUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 2762US2019201352A1Design, synthesis and methods of use of acyclic flexmier nucleoside analogues having anti-coronavirus activityUNIV MARYLAND·Filed 2019·Application pending·0 cites
- 2859US7842719B2Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virusKEMIN FOODS LC·Filed 2003·Granted Nov 30, 2010·1 cites·3 claims
- 2958US10633378B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2014·Granted Apr 28, 2020·0 cites·5 claims
- 3057US11279704B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2019·Granted Mar 22, 2022·0 cites·53 claims
- 3157US2015030563A1Compound for the Treatment of EnterovirusesBIOTA SCIENT MANAGEMENT·Filed 2014·Application pending·0 cites
- 3256US11566025B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2020·Granted Jan 31, 2023·0 cites·18 claims
- 3355US11680084B2Live-attenuated flaviruses with heterologous antigensUNIV LEUVEN KATH·Filed 2018·Granted Jun 20, 2023·0 cites·22 claims
- 3455US10076564B2Bacterial artificial chromosomesUNIV LEUVEN KATH·Filed 2014·Granted Sep 18, 2018·0 cites·20 claims
- 3554US8884011B2Nucleotide analogues as precursor molecules for antiviralsCANARD BRUNO·Filed 2007·Granted Nov 11, 2014·1 cites·17 claims
- 3652US2011224208A1Novel inhibitors of flavivirus replicationUNIV LEUVEN KATH·Filed 2009·Application pending·0 cites
- 3750US2022409583A1Treatment and Prevention of Dengue DiseaseJANSSEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3849US2023241201A1Coronavirus vaccinesUNIV LEUVEN KATH·Filed 2021·Application pending·0 cites
- 3949US2023227537A1Corona virus bindersVIB VZW·Filed 2021·Application pending·0 cites
- 4049US2007128625A1Drug-resistant mutants of hepatitis C virusGILEAD SCIENCES LLC·Filed 2006·Application pending·0 cites
- 4148US2019111125A1Bacterial artificial chromosomesUNIV LEUVEN KATH·Filed 2018·Application pending·0 cites
- 4245US2022168412A1Chimeric Zika-Japanese Encephalitis VirusUNIV LEUVEN KATH·Filed 2020·Application pending·0 cites
- 4344US9730944B2Antiviral activity of novel bicyclic heterocyclesDE JONGHE STEVEN·Filed 2015·Granted Aug 15, 2017·0 cites·9 claims
- 4444US9193741B2Antiviral activity of bicyclic heterocyclesDE JONGHE STEVEN·Filed 2011·Granted Nov 24, 2015·0 cites·20 claims
- 4543US2010137240A1Use of nucleoside derivatives as anti-koi herpes virus in fishUNIV LEUVEN KATH·Filed 2008·Application pending·0 cites
- 4642US2009197910A1Novel viral replication inhibitorsUNIV LEUVEN KATH·Filed 2007·Application pending·0 cites
- 4741US2011206636A1Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever VirusKEMIN FOODS LLC·Filed 2010·Application pending·0 cites
- 4840US11351240B2Chimeric yellow fever ZIKA virus strainUNIV LEUVEN KATH·Filed 2018·Granted Jun 7, 2022·0 cites·20 claims
- 4940US7125853B2Bicyclic carbohydrate compounds useful in the treatment of infections caused by Flaviviridae sp., such as hepatitis C and bovine viral diarrhea virusesKEMIN PHARMA B V B A·Filed 2003·Granted Oct 24, 2006·0 cites·5 claims
- 5026US8153787B2Azacytosine derivatives useful as antiviral agentsHOLY ANTONIN·Filed 2006·Granted Apr 10, 2012·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Johan Neyts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →